Nonclinical findings provide evidence of the mechanism of action of nomlabofusp and support the potential use of skin FXN concentrations as a novel surrogate endpoint for Larimar’s planned BLA ...

Critics will argue that double-blind placebo-controlled trials provide more reliable information than real-world clinical ...

A recent review confirms the safety and efficacy of biosimilar insulins, addressing concerns and promoting their adoption for ...

- NDA assigned a Target Action Date of February 25, 2026 - ...

The high-profile case of the so-called Death Cap Mushroom Cook is likely to remain a topic of conversation across Australia ...

Several medical organisations have filed a lawsuit against RFK Jr and the HHS over recent changes to the US immunisation schedule.